U.S. Life Sciences Stock News

MiMedx Group has published interim findings from its CAMPAIGN trial evaluating EPIEFFECT for nonhealing diabetic foot ulcers. The results show a strong statistical likelihood of outperforming standard wound care approaches. These fresh findings have drawn new attention to the company's wound care platform. See our latest analysis for MiMedx Group. Following the publication of those standout trial results and recent appearances at key industry conferences, MiMedx Group's momentum is in focus...

Wondering if USA Rare Earth stock is truly undervalued or if its current price is just market noise? You are not alone. There is plenty of buzz around this stock’s real worth. It has been a rollercoaster ride recently, with the price down 15.5% over the past week and a steeper 48.1% drop in the last month. However, the stock has managed a 14.4% gain over the past year. Some of these moves come on the heels of big headlines, including a new partnership deal and progress in its Texas-based...

Earlier this month, Apartment List announced the addition of Airbnb-friendly apartments to its platform in 25 cities, enabling renters to easily identify properties permitting Airbnb hosting and expanding this feature over time. This collaboration directly targets the increasing demand for flexible housing options among Gen Z renters, highlighted by research showing strong financial interest in home-sharing solutions. We'll assess how expanded Airbnb-friendly rental options could influence...

Jefferies reiterated a Buy rating on MBX Biosciences after the company reported strong Phase 2 data for its lead hypoparathyroidism therapy, canvuparatide, and announced an upsized public offering expected to raise approximately US$199.9 million to advance its pipeline. This influx of capital positions MBX Biosciences to pursue Phase 3 trials and regulatory interactions with both the FDA and EMA for its novel treatment. We'll examine how the successful fundraise and pipeline progress...

Earlier this week, Zacks Investment Research recommended Federal Signal as a strong growth stock, citing its top Zacks Rank and upward revisions in earnings estimates. Analysts project a 23.6% increase in the company's earnings per share this year, indicating a positive outlook compared to industry averages. We'll explore how Federal Signal's optimistic earnings forecast and Zacks endorsement could influence the company's broader investment narrative. Trump has pledged to "unleash" American...

Amneal Pharmaceuticals recently announced that the U.S. FDA has approved its generic iohexol injection (300 mg Iodine/mL), the first generic version of GE Healthcare’s Omnipaque, with plans to launch in the first quarter of 2026. This approval opens the door for Amneal to compete in a U.S. market for iohexol injections that saw approximately US$652 million in annual sales as of September 2025. We’ll explore how Amneal’s entry into the high-value generic contrast agent market could influence...

Brookfield Wealth Solutions Ltd. announced its board declared a quarterly return of capital of US$0.06 per class A and B share, payable December 31, 2025, while also reporting a very large increase in third quarter net income to US$583 million on revenues of US$2.93 billion. This sharp rise in net income despite steady revenues highlights operational efficiency and ongoing commitment to regular shareholder distributions. We'll explore how Brookfield's surge in quarterly profitability impacts...

On November 20, 2025, TFS Financial Corporation announced that its Board of Directors declared a quarterly cash dividend of $0.2825 per share, set to be paid on December 16 to shareholders of record on December 2. This dividend affirmation, paired with ongoing waivers by its mutual holding company, strengthened coverage for minority shareholders and reinforced TFS Financial's capital stability during ongoing sector challenges. We’ll explore how TFS Financial’s reliable dividend policy shapes...

In recent days, ServiceNow announced a comprehensive suite of integrations with Microsoft, Tanium, Palo Alto Networks, Aria Systems, and Camunda, aiming to expand AI-driven workflow orchestration, security, and automation capabilities across enterprise platforms. This wave of partnerships not only enables proactive management, oversight, and security of AI agents but also positions ServiceNow to address the growing demand for cross-platform enterprise AI solutions with reinforced governance...

Barrick Mining (NYSE:B) has been drawing attention recently as investors weigh its recent performance. Over the past month, the stock climbed 13%, reflecting growing interest in the resource sector as well as underlying company fundamentals. See our latest analysis for Barrick Mining. This latest rally caps off a remarkable run for Barrick Mining, whose share price has soared 39% over the past three months as investors react to renewed optimism around commodities and perceived improvements in...

Merck (MRK) is making waves this week as the company announced a series of meaningful regulatory and clinical updates. Highlights include new FDA and European approvals, as well as encouraging clinical results for important pipeline drugs. See our latest analysis for Merck. Merck’s recent string of regulatory wins and positive clinical trial results has caught investors’ attention, with momentum clearly building. Its 1-month share price return is an impressive 11.7%, while the stock has...

PJT Partners (PJT) is making a strategic move to expand in Europe, announcing plans to hire up to 10 dealmakers and open a new Stockholm office. The office will be led by former Goldman Sachs banker Thomas Westin. This signals the firm's intent to increase its local capabilities in the Nordics. See our latest analysis for PJT Partners. PJT’s expansion in the Nordics comes at a time when momentum in its share price has been uneven, with a 6.92% year-to-date gain but a recent pullback this...

The shift in Knowles (KN) stock caught attention after comments from the president of the Federal Reserve Bank of New York signaled possible rate cuts this December. Lower rates often benefit companies because they reduce financing costs and encourage investment. See our latest analysis for Knowles. Knowles shares spiked after the Fed's dovish signals, though it's been a bumpy ride. Despite a sharp move higher this week, the stock’s 1-month share price return is down 11%. That said, the...

Hub Group's Board of Directors recently declared a quarterly cash dividend of US$0.125 per share for both Class A and Class B stock, payable on December 17, 2025, to shareholders of record as of December 5, 2025, as part of its capital allocation plan. This announcement coincided with Hub Group reporting US$934.5 million in quarterly revenue, which, while showing a 5.3% year-on-year decline, exceeded analyst estimates and highlighted gains in intermodal profitability and the impact of the...

Earlier this week, Nano-X Imaging Ltd. announced a 2026 revenue outlook of US$35 million, alongside expanded commercial partnerships, including a reseller agreement with 3DR Labs and deployments in France, after unveiling its FDA-cleared Nanox.ARC X digital tomosynthesis system at RSNA 2025. This series of developments positions Nano-X Imaging for accelerated international growth and wider adoption of its AI-enhanced imaging solutions within major healthcare networks. Now, we'll explore how...

Earlier this week, GlobalFoundries and Navitas Semiconductor announced a long-term partnership to accelerate U.S.-based gallium nitride (GaN) technology development and manufacturing for high-power applications, aiming for production at GlobalFoundries' Vermont facility in late 2026. This agreement positions GlobalFoundries as an essential supplier in U.S. semiconductor supply chains for critical sectors such as AI datacenters, energy infrastructure, and industrial electrification, while...

Regeneron Pharmaceuticals (REGN) just received FDA approval for its Eylea HD 8 mg injection to treat macular edema following retinal vein occlusion. This approval offers patients the possibility of fewer required treatments compared to previous options. See our latest analysis for Regeneron Pharmaceuticals. The FDA’s green light for Eylea HD comes after a burst of momentum for Regeneron. The company has seen a 30.8% share price return over the last month alone and several promising clinical...

Commercial Metals (CMC) shares edged higher by nearly 3% in the latest session. This quiet move comes as investors continue to weigh the company's recent performance and ongoing trends in the metals sector, as they look for signs of changing momentum. See our latest analysis for Commercial Metals. Commercial Metals’ share price has quietly rallied over 20% so far this year, even as its one-year total shareholder return still lags slightly in negative territory. That mix of recent gains...

ASGN (ASGN) just announced a series of sweeping changes, including a unified Everforth brand rollout, an ambitious $1 billion share buyback, and a new AI Factory framework, all unveiled at its 2025 Investor Day. See our latest analysis for ASGN. ASGN’s big moves have captured attention, but the momentum in its share price has yet to turn around. Even after a 7.45% pop following the Investor Day announcements, the share price is still down 48% year-to-date with a one-year total shareholder...

Grocery Outlet Holding (GO) shares edged higher today, adding just over 3% at the close. Investors appear to be weighing recent performance alongside the company's annual growth in both revenue and net income as they consider its overall valuation. See our latest analysis for Grocery Outlet Holding. Even with a pop to $10.57 today, Grocery Outlet Holding's momentum has been anything but steady this year. After a double-digit drop in the past month and a hefty 45.91% decline in one-year total...

Fortrea Holdings recently completed an oversubscribed debt tender offer, accepting US$75.74 million in principal, and announced the appointment of Agnieszka M. Gallagher as its new general counsel after the planned departure of her predecessor. These developments come as the company faces ongoing shareholder investigations alleging misleading statements on business prospects, signaling active steps to strengthen governance and investor relations. We'll examine how the successful debt tender...

Shares of Stock Yards Bancorp (SYBT) moved higher as investors took notice of comments from the New York Fed President, who hinted at more possible interest rate cuts. This could make borrowing cheaper for banks and their customers. See our latest analysis for Stock Yards Bancorp. Stock Yards Bancorp’s 3.1% share price gain today comes after a tough stretch for the stock, with momentum still searching for a foothold. This follows a freshly declared dividend and a recent investor conference...

Kennametal (KMT) shares have seen some movement recently, catching the eye of investors interested in capital goods trends. With the stock up around 18% over the past month, many are watching to see what is driving this momentum. See our latest analysis for Kennametal. After a bumpy period earlier this year, Kennametal’s recent 17.8% 1-month share price return and a strong 24.6% gain over the past quarter suggest momentum is building again, even if the total shareholder return over the past...

On November 20, 2025, Linde plc completed a multi-tranche €1.75 billion debt offering, including €600 million floating rate notes due 2027, €650 million 3.125% notes due 2032, and €500 million 3.750% notes due 2038, with proceeds allocated for general corporate purposes and listing on the Luxembourg Stock Exchange. This significant financing activity reflects Linde's continued access to European debt markets and highlights its ability to fund long-term growth initiatives and investment...